# iTBS+D-Cycloserine for Youth Suicide

> **NCT06121284** · PHASE2 · RECRUITING · sponsor: **University of Calgary** · enrollment: 54 (estimated)

## Conditions studied

- Suicidal Ideation
- Suicide, Attempted
- Depression, Anxiety

## Interventions

- **DRUG:** D-Cycloserine
- **DEVICE:** intermittent Theta-Burst-repetitive Transcranial Magnetic Stimulation
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT06121284
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-11
- **Primary completion:** 2026-07
- **Final completion:** 2026-09
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2024-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06121284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06121284, "iTBS+D-Cycloserine for Youth Suicide". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06121284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*